These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
814 related articles for article (PubMed ID: 26412471)
1. Efficiency of transcatheter patent foramen ovale closure in children after paradoxical embolism events. Wawrzyńczyk M; Gałeczka M; Karwot B; Knop M; Białkowski J Kardiol Pol; 2016; 74(4):385-9. PubMed ID: 26412471 [TBL] [Abstract][Full Text] [Related]
2. Medium-term results of transcatheter closure of patent foramen ovale (PFO) with Amplatzer PFO and Cribriform occluders. Białkowski J; Wawrzyńczyk M; Karwot B; Fiszer R; Knop M; Szkutnik M Kardiol Pol; 2012; 70(11):1142-6. PubMed ID: 23180522 [TBL] [Abstract][Full Text] [Related]
3. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial. Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L; JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037 [TBL] [Abstract][Full Text] [Related]
4. Long-term experience and outcomes with transcatheter closure of patent foramen ovale. Inglessis I; Elmariah S; Rengifo-Moreno PA; Margey R; O'Callaghan C; Cruz-Gonzalez I; Baron S; Mehrotra P; Tan TC; Hung J; Demirjian ZN; Buonanno FS; Ning M; Silverman SB; Cubeddu RJ; Pomerantsev E; Schainfeld RM; Dec GW; Palacios IF JACC Cardiovasc Interv; 2013 Nov; 6(11):1176-83. PubMed ID: 24262618 [TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience. Taggart NW; Reeder GS; Lennon RJ; Slusser JP; Freund MA; Cabalka AK; Cetta F; Hagler DJ Catheter Cardiovasc Interv; 2017 Jan; 89(1):124-133. PubMed ID: 27027873 [TBL] [Abstract][Full Text] [Related]
6. Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices. Bissessor N; Wong AW; Hourigan LA; Jayasinghe RS; Scalia GS; Burstow DJ; Griffiths LR; Savage M; Walters DL Cardiovasc Revasc Med; 2011; 12(3):164-169. PubMed ID: 21640934 [TBL] [Abstract][Full Text] [Related]
7. Patent foramen ovale and unexplained ischemic cerebrovascular events in children. Benedik MP; Zaletel M; Meglic NP; Podnar T Catheter Cardiovasc Interv; 2007 Dec; 70(7):999-1007. PubMed ID: 18044736 [TBL] [Abstract][Full Text] [Related]
8. Transcranial Doppler quantification of residual shunt after percutaneous patent foramen ovale closure. Comparison of two devices. Sorensen SG; Aguilar H; McKnight WK; Thomas H; Muhlestein JB J Interv Cardiol; 2010 Dec; 23(6):575-80. PubMed ID: 20796165 [TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism. Cifarelli A; Musto C; Parma A; Pandolfi C; Pucci E; Fiorilli R; De Felice F; Nazzaro MS; Violini R Int J Cardiol; 2010 Jun; 141(3):304-10. PubMed ID: 19178959 [TBL] [Abstract][Full Text] [Related]
10. Diagnosis of secondary source of right-to-left shunt with balloon occlusion of patent foramen ovale and power M-mode transcranial Doppler. Jesurum JT; Fuller CJ; Renz J; Krabill KA; Spencer MP; Reisman M JACC Cardiovasc Interv; 2009 Jun; 2(6):561-7. PubMed ID: 19539262 [TBL] [Abstract][Full Text] [Related]
11. Second transcatheter closure for residual shunt following percutaneous closure of patent foramen ovale. Susuri N; Obeid S; Ulmi M; Siontis GCM; Wahl A; Windecker S; Nietlispach F; Meier B; Praz F EuroIntervention; 2017 Sep; 13(7):858-866. PubMed ID: 28437244 [TBL] [Abstract][Full Text] [Related]
12. Transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Procedural and follow-up results after implantation of the Starflex occluder device with conjunctive intensified anticoagulation regimen. Fischer D; Fuchs M; Schaefer A; Schieffer B; Jategaonkar S; Hornig B; Drexler H; Meyer GP J Interv Cardiol; 2008 Apr; 21(2):183-9. PubMed ID: 18312307 [TBL] [Abstract][Full Text] [Related]
13. Long term follow up after percutaneous closure of PFO in 357 patients with paradoxical embolism: Difference in occlusion systems and influence of atrial septum aneurysm. von Bardeleben RS; Richter C; Otto J; Himmrich L; Schnabel R; Kampmann C; Rupprecht HJ; Marx J; Hommel G; Münzel T; Horstick G Int J Cardiol; 2009 May; 134(1):33-41. PubMed ID: 18715659 [TBL] [Abstract][Full Text] [Related]
14. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events. Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668 [TBL] [Abstract][Full Text] [Related]
15. Percutaneous transcatheter closure of high-risk patent foramen ovale in the elderly. Takafuji H; Hosokawa S; Ogura R; Hiasa Y Heart Vessels; 2019 Oct; 34(10):1657-1662. PubMed ID: 30868214 [TBL] [Abstract][Full Text] [Related]
16. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer®-occluder device. Fischer D; Haentjes J; Klein G; Schieffer B; Drexler H; Meyer GP; Schaefer A J Interv Cardiol; 2011 Feb; 24(1):85-91. PubMed ID: 20735710 [TBL] [Abstract][Full Text] [Related]
17. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism. Chatterjee T; Petzsch M; Ince H; Rehders TC; Körber T; Weber F; Schneider H; Auf der Maur C; Nienaber CA J Interv Cardiol; 2005 Jun; 18(3):173-9. PubMed ID: 15966921 [TBL] [Abstract][Full Text] [Related]